Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review by Arnold G. Vulto, Jackie Vanderpuye-Orgle, Martin van der Graaff, Steven R. A. Simoens, Lorenzo Dagna, Richard Macaulay, Beenish Majeed, Jeffrey Lemay, Jane Hippenmeyer, Sebastian Gonzalez-McQuire

Subjects: “…biosimilar market…”
Get full text

Biosimilar insulins in international and domestic practice of pharmacist by I. O. Vlasenko, I. V. Nizhenkovska

Subjects: “…biosimilar…”
Get full text

The Breakthrough of Biosimilars: A Twist in the Narrative of Biological Therapy by Eva Rahman Kabir, Shannon Sherwin Moreino, Mohammad Kawsar Sharif Siam

Subjects: “…biosimilar…”
Get full text

Authorisation of Non-Innovator Biotherapeutic (Biosimilar) Products in the USA by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. D. Mosyagin

Subjects: Get full text

Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review by Fox GE, Bernauer M, Stephens JM, Jackson B, Roth JA, Shelbaya A

Subjects: “…biosimilar…”
Get full text

Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience by Martina Maurelli, Giampiero Girolomoni, Paolo Gisondi

Subjects: Get full text

Estudio observacional de cambio de producto de referencia de Etanercept a biosimilar en una población de pacientes con artritis reumatoidea de un hospital de tercer nivel by Mayra Castillo Jurado, Ruth Almeida Guillén, Lissette Vélez Mejía, José Triana Santillán, Ignacio Alcívar Guerra, Roberto Florencia Peña, Liudmila Maldonado Romero

Subjects: “…biosimilar…”
Get full text

Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia by Otremba B, Hielscher C, Petersen V, Petrik C

Subjects: Get full text

Implementing a Medication Switching Policy: Analysis of the Saskatchewan Biosimilars Initiative by Kirsten Fox

Subjects: Get full text

Pharmacokinetics, safety, and immunogenicity of HLX03, an adalimumab biosimilar, compared with reference biologic in healthy Chinese male volunteers: Results of a randomized, doubl... by Hong Zhang, Min Wu, Jixuan Sun, Xiaoxue Zhu, Cuiyun Li, Yanhua Ding, Xiaodi Zhang, Katherine Chai, Xiaojiao Li

Subjects: Get full text

The results of investigating the efficacy and safety of non-medical switching from the original rituximab to its biosimilar in rheumatoid arthritis patients (AMBIRA study) by M. A. Korolev, Yu. B. Ubshaeva, N. Y. Banshchikova, E. A. Letyagina, A. A. Mullagaliev

Subjects: Get full text

Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis by Yasameen Abbas, Nabaa Ihsan, Asal Adnan, Marwa Moayad, Ali AlKazzaz, Avin Maroof, Ali Abdulrahman, Nazar Abdulateef, Mohammad AlOsami, Faiq Gorial, Mohammed Altahhan, Zahraa Almansi, Ali Alnoori

Subjects: Get full text

Real‐world clinical effectiveness and safety of CT‐P10 in patients with diffuse large B‐cell lymphoma: An observational study in Europe by Mark J. Bishton, Gilles Salles, Camille Golfier, Wolfgang Knauf, Monica Bocchia, Deborah Turner, Borhane Slama, Jatinder Harchowal, Scott Marshall, Alberto Bosi, Juan José Bargay Lleonart, Manfred Welslau, SooKyoung Kim, Young N. Lee, Pier L. Zinzani, Kamel Laribi

Subjects: “…biosimilar…”
Get full text

A prospective, randomized, double-blind, comparative clinical study of efficacy and safety of a biosimilar adalimumab with innovator product in patients with active rheumatoid arth... by Prasad Apsangikar, Sunil Chaudhry, Manoj Naik, Shashank Deoghare, Jamila Joseph

Subjects: Get full text

THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY) by E. L. Nasonov, E. V. Zonova, O. N. Ivanova, L. A. Knyazeva, V. I. Mazurov, R. R. Samigullina, I. M. Marusenko, O. B. Nesmeyanova, T. V. Plaksina, A. E. Sizikov, D. G. Krechikova, N. A. Petrochenkova, Yu. S. Shapovalova, N. S. Soroka, S. I. Pimanov, A. M. Pristrom, E. V. Kunder, E. V. Chernyaeva, A. V. Eremeeva, R. Ivanov

Subjects: Get full text

A phase 1, randomized, open-label, single-dose study to assess the relative bioavailability of a subcutaneous dose of FKB327 when administered using a prefilled syringe, a prefille... by Jim Bush, Kazuki Kawakami, Rafael Muniz

Subjects: Get full text

Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes by Alireza Lashay, Hooshang Faghihi, Ahmad Mirshahi, Hassan Khojasteh, Alireza Khodabande, Hamid Riazi-Esfahani, Fahimeh Asadi Amoli, Elias Khalili Pour, Elham Delrish

Subjects: “…biosimilar…”
Get full text

A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility by Gizzo S, Garcia-Velasco JA, Heiman F, Ripellino C, Bühler K

Subjects: Get full text

LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects by Guoying Cao, Jingjing Wang, Jinjie He, Yingying Hu, Haijing Yang, Linling Que, Xianghong Gu, Jicheng Yu, Xiaojie Wu, Jufang Wu, Wei Fang, Qing He, Jing Zhang

Subjects: “…biosimilar…”
Get full text

Biosimilars and the extrapolation of indications for inflammatory conditions by Tesser JRP, Furst DE, Jacobs I

Subjects: “…biosimilar…”
Get full text